Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

The pharmaceutical giant will build seven new facilities and a $1.1 billion research hub in San Diego, aiming to bolster domestic drug production and create thousands of jobs.

• Novartis has announced a $23 billion investment over five years to expand its U.S. operations, including seven new facilities and a research hub in San Diego.
• The $1.1 billion San Diego research hub will focus on drug discovery and complement existing R&D centers in Cambridge, MA, and Basel, Switzerland.
• The investment is expected to create nearly 1,000 direct jobs at Novartis and approximately 4,000 additional roles across the U.S., including construction and support positions.
• The initiative aligns with Novartis' U.S.-first strategy, ensuring that all key medicines for U.S. patients are produced domestically.
• The announcement follows President Trump's pledge to impose tariffs on imported pharmaceuticals, though Novartis states tariffs were not the primary driver of this decision.

3 Articles

Townhall Times of San Diego The Straits Times